CGIX

Cancer Genetics, Inc. Press Releases

$8.6899
*  
0.1099
1.28%
Get CGIX Alerts
*Delayed - data as of Sep. 17, 2014 9:52 ET  -  Find a broker to begin trading CGIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CGIX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cancer Genetics, Inc. to Present at Aegis Healthcare and Technology Conference on Thursday, September 11, 2014
9/10/2014 7:59:00 AM - GlobeNewswire

Cancer Genetics' Proprietary IVD for Cervical Cancer, FHACT(R), Receives CE
9/2/2014 8:15:00 AM - GlobeNewswire

Cancer Genetics' Proprietary Genomic Diagnostic Tests Added to National Institutes of Health's Genetic Testing Registry
8/27/2014 7:59:00 AM - GlobeNewswire

Cancer Genetics, Inc. and Leading Pathologist From Keck Medicine of USC Collaborate to Evaluate and Optimize Genomic Panel for Lymphoma
8/25/2014 7:59:00 AM - GlobeNewswire

Cancer Genetics Inc. Completes Acquisition of BioServe India, a Premier Genomics and Next-Generation Sequencing Company
8/18/2014 12:00:00 AM - GlobeNewswire

Cancer Genetics Reports Second Quarter 2014 Financial Results
8/14/2014 7:05:00 AM - GlobeNewswire

Cancer Genetics to Report Second Quarter 2014 Financial Results on Thursday, August 14, 2014
8/8/2014 8:56:00 AM - GlobeNewswire

Cancer Genetics, Inc. Releases the Only Comprehensive Genomic Test to Diagnose & Stratify the Most Common Form of Leukemia (CLL)
8/4/2014 7:30:00 AM - GlobeNewswire

Cancer Genetics, Inc. to Present at the Canaccord Genuity 34th Annual Growth Conference
7/22/2014 8:00:00 AM - GlobeNewswire

Cancer Genetics Announces Acquisition of Gentris Corporation, a Leading Global Pharmacogenomics Company, and Increases Contract Backlog to Over $18 Million
7/21/2014 7:45:00 AM - GlobeNewswire

Cancer Genetics to Acquire Gentris Corporation, a Global Leader in Pharmacogenomic Profiling for Therapeutic Development, Companion Diagnostics & Clinical Trials
6/23/2014 8:36:00 AM - GlobeNewswire